Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10636 (
tau protein
)
5,110
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Niemann-Pick disease, type C1
(
NPC1
) is a lipid storage disorder that results in progressive neurological impairment. The
NPC1
phenotype is extremely variable and at the individual level is likely influenced by other genetic traits. In addition to residual function of
NPC1
protein, we hypothesize that modifier genes, as frequently observed with other autosomal recessive diseases, influence the NPC phenotype. The
NPC1
phenotype includes progressive dementia, and the NPC pathology has some overlap with the pathology of Alzheimer disease (AD). Thus, we examined apolipoprotein E (ApoE) and
microtubule-associated protein tau
(
MAPT
) polymorphisms in a cohort of 15
NPC1
patients with well characterized longitudinal disease progression. Although we did not find any correlations between disease severity and tau polymorphisms, we found significant associations between ApoE polymorphisms and phenotypic severity. Specifically, ApoE4 and ApoE2 alleles were associated, respectively, with increased and decreased disease severity in this cohort of
NPC1
patients. These data support the hypothesis that ApoE may play a role in modulating
NPC1
neuropathology.
...
PMID:Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. 2302 45